Biotech's Vanguard: Novo Nordisk, Omeros, and GSK Charting New Territories in Medical Innovation

Novo Nordisk Shifts Focus: Why the Cell Therapy Unit is Closing Its Doors

Nuvation Bio Soars: Pioneering Trial Success Ignites "Buy" Rating from Jefferies

Zevra Therapeutics Shares Skyrocket Amid Intense Takeover Speculation

Market Meltdowns & Mega-Deals: Unpacking Today's Biggest Stock Movers

Agios Shares Plummet as FDA Halts Pyrukynd's Thalassemia Review, Sending Shockwaves Through Biotech